Western media outlets have continued to report on alleged Chinese espionage in the medical technology and biotechnology sectors, with recent focus shifting toward vulnerabilities in Chinese-manufactured medical devices that could enable data theft or unauthorized access.
The most recent development came in early March 2026, when Fox News reported that Texas Governor Greg Abbott issued a directive warning state health agencies and public university systems about potential Chinese spying via medical technology. Abbott ordered reviews of cybersecurity policies for Chinese-made devices, stating, “The Chinese Communist Party will not be allowed to spy on Texans.” This followed alerts from the U.S. Food and Drug Administration (FDA) and Cybersecurity and Infrastructure Security Agency (CISA) highlighting backdoors in patient monitors like the Contec CMS8000 and Epsimed MN-120. These vulnerabilities could permit remote access, configuration changes, and exfiltration of protected health information (PHI), including vital signs data. Fox News and other outlets noted the devices’ hardcoded IP addresses linked to anomalous traffic, raising fears of state-sponsored exploitation.
In late 2025 and early 2026, Fox News covered broader concerns, including an October 2025 opinion piece warning that Chinese-made medical devices in U.S. hospitals pose risks of data theft and supply chain vulnerabilities. The piece urged increased domestic manufacturing to counter threats from the Chinese Communist Party. Earlier in 2025, Florida Attorney General James Uthmeier subpoenaed Contec Medical Systems over alleged “compromised” devices with backdoors enabling manipulation and private data transmission, as reported by Fox News.
Biotechnology-related allegations persisted. In 2025, cases involved Chinese nationals accused of smuggling biological materials or pathogens, such as a fungus described as a “dangerous biological pathogen” into the U.S. for research at the University of Michigan, per BBC and Fox News coverage. Other incidents included a Chinese PhD student from Wuhan arrested for smuggling biological materials and deleting evidence, and a researcher at MD Anderson accused of attempting to smuggle cancer research data to China.
U.S. scrutiny of firms like WuXi AppTec continued from prior years, with intelligence concerns about IP transfers to Beijing without consent, though recent reports emphasized device-level risks over corporate partnerships.
